AME vs TXG · P/E 30, rev $2.04B vs rev $301.9M
Ametek Inc (AME) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Ametek Inc (AME) is a specialty industrial machinery company listed on US.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported AME revenue for 2026-06-30 was $2.04B. Net income was $406.9M. Revenue was up 6.0% from 2026-03-31 to 2026-06-30. AME currently screens at market cap $42.11B and trailing P/E 29.9.
Latest reported TXG revenue for 2026-06-30 was $301.9M. Net income was -$31.4M. TXG currently screens at market cap $4.08B.
AME currently screens at market cap $42.11B and trailing P/E 29.9. TXG currently screens at market cap $4.08B.
Not investment advice. Open the AME and TXG stock pages for the full models.
Not investment advice.